aod9604 clinical trials efficacy fat loss AOD‑9604 Peptide for Loss: Mechanism, Benefits & Risks Explained You’re Injecting AOD-9604 WRONG! Doctor

Daily intraperitoneal administration for 11 days reduced body weight gain, decreased white adipose tissue mass by approximately 35%, and reduced adipocyte size, while food intake between treated and control groups did not differ significantly

Because the shot is fast and performed by trained staff, many patients find that the convenience outweighs any temporary discomfort

Boost your energy levels naturally

Under the guidance of a licensed provider, B12 injections can help restore optimal levels by bypassing the digestive system for improved absorption

This absence of hyperglycemic effects makes the peptide safer for individuals concerned about glucose metabolism, and the lack of IGF-1 elevation reduces theoretical concerns about cell proliferation

Lower NAD+ means reduced sirtuin activity (SIRT1, SIRT3), which further impairs mitochondrial function and fatty acid oxidation in fat cells